FDA Drug recall D-0473-2017
SLIMFIT X capsules, packaged in a 60-cont bottle
- FDA Drug
- Class I
- terminated
- Published 2017-02-22
On 2017-02-22 the FDA classified a Class I recall of SLIMFIT X capsules, packaged in a 60-cont bottle by Jersey Shore Supplements, citing marketed without an approved NDA/ANDA: Product contains undeclared sibutramine and desmethylsibutramine.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0473-2017 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2016-12-09 |
| Published | 2017-02-22 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Jersey Shore Supplements |
| Distribution | MD, NJ |
Product
SLIMFIT X capsules, packaged in a 60-cont bottle
Reason
Marketed without an approved NDA/ANDA: Product contains undeclared sibutramine and desmethylsibutramine.
Identifiers
| code_info | All lots and all expiration dates. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0473-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.